Huaan Securities released a research report on April 28 stating that it gave Dian Diagnosis (300244.SZ) a purchase rating. The main reasons for the rating include: 1) short-term performance is under pressure, and the scale effect remains the same; 2) regular business continues to grow, and the growth rate of special inspection business is stable. (Mainichi Keizai Shimbun)
华安证券4月28日发布研报称，给予迪安诊断（300244.SZ）买入评级。评级理由主要包括：1）业绩短期承压，规模效应依旧；2）常规业务保持增长，特检业务增速稳定。（每日经济新闻）
Huaan Securities released a research report on April 28 stating that it gave Dian Diagnosis (300244.SZ) a purchase rating. The main reasons for the rating include: 1) short-term performance is under pressure, and the scale effect remains the same; 2) regu
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.